The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
Open accessAbstract
BACKGROUND: Inorganic nanoparticles provide promising tools for biomedical applications including detection, diagnosis and therapy. While surface properties such as charge are expected to play an important role in their in vivo behavior, very little is known how the surface chemistry of nanoparticles influences their pharmacokinetics, tumor uptake, and biodistribution. METHOD/PRINCIPAL FINDINGS: Using a family of structurally homologous nanoparticles we have investigated how pharmacological properties including tumor uptake and biodistribution are influenced by surface charge using neutral (TEGOH), zwitterionic (Tzwit), negative (TCOOH) and positive (TTMA) nanoparticles. Nanoparticles were injected into mice (normal and athymic) either in the tail vein or into the peritoneum. CONCLUSION: Neutral and zwitterionic nanoparticles demonstrated longer circulation time via both i.p. and i.v. administration, whereas negatively and positively charged nanoparticles possessed relatively short half-lives. These pharmacological characteristics were reflected on the tumor uptake and biodistribution of the respective nanoparticles, with enhanced tumor uptake by neutral and zwitterionic nanoparticles via passive targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The bio-distribution of intraperitoneally and intravenously administrated nanoparticles is similar (48).”
From Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps (2016) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system
Brust, M., Walker, M., Bethell, D., Schiffrin, D. J., & Whyman, R. (1994) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39940000801 · Cited by 6,714
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. M. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,236
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Fang, J. Q., Nakamura, H., & Maeda, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,573
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Designing materials for biology and medicine
Langer, R., & Tirrell, D. A. (2004) · Nature · doi:10.1038/nature02388 · Cited by 3,198
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–404 of 404
Tailoring virus-inspired nanoparticles for advanced drug and gene delivery
Zhou, R., Xu, M., Zheng, X., Xu, J., Li, J., Tong, H., Zhao, C., Han, J., Luo, L., & Li, H. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103219
In Vivo CAR-Based Immune Cell Engineering: Future Applications and Challenges in Malignant Glioma
Yamaguchi, J., Bergquist, A., Lu, J., Lakshmanachetty, S., Khan, S. H., & Okada, H. (2026) · Cancers · doi:10.3390/cancers18121986
Xie, Z., Zhang, L., Yin, C., Zhang, X., & Lu, Y. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070799
Self-Therapeutic Noble Metal Nanoparticles: Promise and Considerations for Clinical Translation
Luo, Q., Wong, H. L., Muljadi, M. B., Guo, Y., Chao, H. I., Verminshu, B. A., Chen, Y., Wang, J., & Choi, C. H. J. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00166
Metadata
- Authors
- Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., & Mukherjee, P.
- Affiliations
- Mayo Clinic (US)
- University of Massachusetts Amherst (US)
- University of Missouri (US)
- Corresponding author
- Mukherjee, Priyabrata
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-09-13
- Volume
- 6
- Issue
- 9
- Pages
- e24374
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3172229
- OpenAlex
- W2053311966
- Cited by
- 403
- References
- 43
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 25 · 2023: 27 · 2022: 27 · 2021: 36 · 2020: 37 · 2019: 41 · 2018: 23 · 2017: 34 · 2016: 30 · 2015: 24 · 2014: 21 · 2013: 27 · 2012: 11
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (GM077173)
- National Cancer Institute (R01CA136494, CA135001, CA136494)
- National Institute of General Medical Sciences (GM-077173, R01GM077173)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Keywords
- engineered nanoparticles, surface charge, surface chemistry, pharmacokinetics, tumor uptake, tissue distribution, circulation time, zwitterionic nanoparticles, passive targeting, nanoparticle clearance, nude mice, intraperitoneal injection, intravenous injection
- MeSH terms
- Animals, Gold, Ligands, Male, Neoplasms, Surface Properties, Time Factors, Tissue Distribution, Nanotechnology, Cell Line, Tumor, Mice, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
